PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Gynecologic Oncology, Department of Surgical Oncology, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada.\', \'Division of Gynecologic Oncology, Brigham and Women\'s Hospital, Dana Farber Cancer Institute, Boston, MA, USA.\', \'Division of Gynecologic Oncology, Department of Surgical Oncology, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada; Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON, Canada.\', \'Division of Gynecologic Oncology, Department of Surgical Oncology, Princess Margaret Cancer Center, University of Toronto, Toronto, ON, Canada; Department of Obstetrics and Gynecology, University of Toronto, Toronto, ON, Canada. Electronic address: Taymaa.May@uhn.ca.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0090-8258(21)00350-410.1016/j.ygyno.2021.04.030
?:doi
?:hasPublicationType
?:journal
  • Gynecologic oncology
is ?:pmid of
?:pmid
?:pmid
  • 33941382
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.339
?:rankingScore_hIndex
  • 141
is ?:relation_isRelatedTo_publication of
?:title
  • Gynecologic oncology treatment modifications or delays in response to the COVID-19 pandemic in a publicly funded versus privately funded North American tertiary cancer center.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33941382>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33941382>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all